Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001104659-22-035096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | A - Grant | $0.00 | +32.4K | 1.52M | +2% | $0 |
| DI | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | F - Tax | $34.74 | -4,786 | 1.52M | -0.3% | -$166.3K |
| D | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | F - Tax | $34.74 | -14.8K | 2.38M | -0.6% | -$512.7K |
| D | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | A - Grant | $0.00 | +76.9K | 2.40M | +3% | $0 |
| D | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | A - Grant | $0.00 | +177.5K | 177.5K | New | $0 |
| DI | 2022-03-17 | 2022-03-15 | AMPH | Luo Mary Z. | CEO, CSO, Dir, 10% | A - Grant | $0.00 | +74.8K | 74.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | A | A | 32,412 | $0.00 | 1,520,783 | I | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2023. |
| 2 | Common | Common Stock | 2022-03-15 | F | D | 4,786 | $34.74 | 1,515,997 | I | — | — | (F2) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. |
| 3 | Common | Common Stock | 2022-03-15 | F | D | 14,759 | $34.74 | 2,383,023 | D See footnote | — | — | (F2) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. (F3) The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. |
| 4 | Common | Common Stock | 2022-03-15 | A | A | 76,914 | $0.00 | 2,397,782 | D See footnote | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2023. (F3) The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2022-03-15 | A | A | 177,461 | $0.00 | 177,461 | D See footnote | $34.74 · — to 2032-03-15 | 177,461 Common Stock | (F3) The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. (F6) The shares subject to the option vest in four equal annual installments beginning on March 15, 2023. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-03-15 | A | A | 74,784 | $0.00 | 74,784 | I | $34.74 · — to 2032-03-15 | 74,784 Common Stock | (F6) The shares subject to the option vest in four equal annual installments beginning on March 15, 2023. |